Format
Sort by
Items per page

Send to

Choose Destination

Best matches for endocrine therapy AND hormone replacement therapy AND mortality vital statistics AND postmenopause:

Search results

Items: 10

1.

Long-Term Follow-Up of the Intergroup Exemestane Study.

Morden JP, Alvarez I, Bertelli G, Coates AS, Coleman R, Fallowfield L, Jassem J, Jones S, Kilburn L, Lønning PE, Ortmann O, Snowdon C, van de Velde C, Andersen J, Del Mastro L, Dodwell D, Holmberg S, Nicholas H, Paridaens R, Bliss JM, Coombes RC.

J Clin Oncol. 2017 Aug 1;35(22):2507-2514. doi: 10.1200/JCO.2016.70.5640. Epub 2017 May 3.

PMID:
28467729
2.

[Ethinylestradiol Following Everolimus plus Exemestane Was Effective in Postmenopausal Endocrine-Responsive Metastatic Breast Cancer - A Case Report].

Matsuoka A, Hirano A, Hattori A, Ogura K, Inoue H, Yukawa H, Sakaguchi S, Tanaka N, Kodera A, Kamimura M, Naritaka Y, Shimizu T.

Gan To Kagaku Ryoho. 2016 Oct;43(10):1219-1222. Japanese.

PMID:
27760942
3.

Adjuvant endocrine therapy in premenopausal women with breast cancer.

Kadakia KC, Henry NL.

Clin Adv Hematol Oncol. 2015 Oct;13(10):663-72.

4.
5.

Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research Consortium.

Yardley DA, Burris HA 3rd, Clark BL, Shipley D, Rubin M, Barton J Jr, Arrowsmith E, Hainsworth JD.

Clin Breast Cancer. 2011 Jun;11(3):146-52. doi: 10.1016/j.clbc.2011.03.010. Epub 2011 Apr 20.

PMID:
21665134
6.
7.

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

Rodriguez C, Patel AV, Calle EE, Jacob EJ, Thun MJ.

JAMA. 2001 Mar 21;285(11):1460-5.

PMID:
11255422
8.

Menopause and post-menopause.

Prelevic GM, Jacobs HS.

Baillieres Clin Endocrinol Metab. 1997 Jul;11(2):311-40. Review.

PMID:
9403125
9.

Influence of plasma estrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer.

Lønning PE, Helle SI, Johannessen DC, Ekse D, Adlercreutz H.

Breast Cancer Res Treat. 1996;39(3):335-41.

PMID:
8877014
10.

Postmenopausal hormone use and risk of large-bowel cancer.

Newcomb PA, Storer BE.

J Natl Cancer Inst. 1995 Jul 19;87(14):1067-71. Erratum in: J Natl Cancer Inst 1995 Sep 20;87(18):1416.

PMID:
7616598

Supplemental Content

Loading ...
Support Center